Positron Corporation (POSC)

[Bayou Man]

News for 'POSC' - (Positron Announces Strategic Alliance with Covidien; to Develop Innovative Distribution Model)


INDIANAPOLIS, Aug 19, 2010 (BUSINESS WIRE) -- Positron Corporation
(OTCBB:POSC), announced it has signed an agreement with Covidien (NYSE:COV), a
leading global provider of healthcare products, under which Covidien will
provide technical assistance to Positron in connection with Positron's
development of technology to automate the compounding of radiopharmaceuticals.

The agreement combines Covidien's expertise in radiopharmaceuticals and
regulatory issues with Positron's expertise in automation and
radiopharmaceuticals. Automating the distribution of radiopharmaceuticals has
many benefits, ranging from worker safety to cost savings to enhanced customer
service.

"Positron continues to provide unique solutions to the molecular imaging
community," said John Zehner, COO of Positron. "This agreement provides Positron
with various advantages and additional resources. We are very excited to
collaborate with Covidien on this project."

About Positron: Positron is a molecular imaging company focused on Nuclear
Cardiology. Positron utilizes its proprietary product line to provide unique
solutions to the Nuclear Medicine community ranging from imaging to
radiopharmaceutical distribution. Positron products include: the Attrius(TM), a
PET imaging device; the Pulse(R), a SPECT imaging device; the Nuclear
Pharm-Assist(R), an automated radiopharmaceutical distribution device; and the
Tech-Assist(TM), a radiopharmaceutical injection shield. More information about
Positron is available at www.positron.com.

Forward Looking Statements: Statements in this document contain certain
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended.
These statements are based on many assumptions and estimates and are not
guarantees of future performance and may involve known and unknown risks,
uncertainties and other factors which may cause the actual results, performance
or achievements of Positron Corporation to be materially different from future
results, performance or achievements expressed or implied by such
forward-looking statements. Positron assumes no obligation to publicly update or
revise these forward-looking statements for any reason, or to update the reasons
actual results could differ materially from those anticipated in these
forward-looking statements, even if new information becomes available in the
future. Our actual results may differ materially from the results anticipated in
these forward-looking statements due to a variety of factors, including, without
limitation those set forth as "Risk Factors" in our filings with the Securities
and Exchange Commission.

SOURCE: Positron Corporation



CONTACT:
Positron Corporation
John Zehner, 317-576-0183




Copyright Business Wire 2010

-0-




KEYWORD: United States

North America

Indiana

INDUSTRY KEYWORD: Health

Biotechnology

Cardiology

Medical Devices

Pharmaceutical

Radiology

Medical Supplies

General Health

SUBJECT CODE: Contract/Agreement



Source: Comtext Market News